Nasal cavity hemostasis equipment

By designing a nasal hemostasis device including a limiting block, a slider, a medicine-administered member and a hollow tube, the problem of blocking channels when stopping both nasal cavity at the same time in the prior art is solved, and the effect of stopping bleeding is achieved without hindering normal breathing and making use more comfortable.

CN222853934UActive Publication Date: 2025-05-13THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202421263057.6
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-06-04
Publication Date
2025-05-13
Estimated Expiration
2034-06-04

AI Technical Summary

Technical Problem

When the existing nasal hemostasis stops bleeding from both nasal cavity at the same time, the airbags are stuffed into the nasal cavity to block the passage, causing the patient to breathe with his mouth. Long-term breathing with his mouth causes dryness in the throat and oral mucosa, which makes it uncomfortable to use.

Method used

A nasal hemostasis device is designed, including an inflatable assembly and a hemostasis assembly. The hemostasis assembly is composed of a limit block, a slider, a medicine-administered member and a hollow tube. The slider and a limit block are used in conjunction with each other to adjust the position and distance of the hollow tube to ensure that the airbag layer and hemostasis cotton can effectively stop bleeding, and at the same time, the patient's normal breathing is ensured through the hollow hole, the connecting hole and the through-groove structure.

Benefits of technology

It achieves that the patient's normal breathing is not hindered when hesitating both nasal cavity at the same time, and avoids drying of the throat and oral mucosa caused by long-term breathing with the mouth, making it more comfortable to use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222853934U_ABST
    Figure CN222853934U_ABST
Patent Text Reader

Abstract

The utility model relates to the technical field of medical instruments, in particular to a nasal cavity hemostasis device which comprises an inflation assembly and a hemostasis assembly, the hemostasis assembly comprises a limiting block, a hollow pipe, two sliding blocks and a medicine applying component, the two sliding blocks are respectively connected with the limiting block in a sliding mode and located at the top of the limiting block, and the medicine applying component is connected with the hollow pipe. The tops of the two sliding blocks are fixedly connected with hollow pipes respectively, the hollow pipes are provided with hollow holes, the sliding blocks are provided with connecting holes, the limiting block is provided with a through groove, the hollow holes, the connecting holes and the through groove are communicated with one another, and the medicine applying component is connected with the hollow pipes. The two central tubes are plugged into the nasal cavity of a patient, the medicine applying component makes contact with the interior of the nasal cavity for pressing hemostasis, breathing of the patient is conducted through the hollow holes, the connecting holes and the through grooves, normal breathing is not hindered while hemostasis is conducted, and use is more comfortable.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of medical instruments, in particular to a nasal hemostasis device. Background Art

[0002] Nosebleed refers to the rupture of blood vessels in the nasal cavity and surrounding tissues, with blood flowing forward through the nostrils or backward into the oropharynx. Currently, patients with nosebleeds are treated by filling the nasal cavity with hemostatic cotton to stop the bleeding, but the effect is poor.

[0003] The existing announcement number CN202060822U discloses a nasal hemostat, including a left air bag and a right air bag, the left air bag and the right air bag are covered with a hemostatic cotton layer, the left air bag is connected to the left inflation tube, the left inflation tube is provided with a left control valve, the right air bag is connected to the right inflation tube, the right inflation tube is provided with a right control valve, the left inflation tube and the right inflation tube are connected to the main inflation tube, the main inflation tube is connected to the air bag, the nasal cavity is pressurized and hemostatic, and the hemostatic cotton layer on the outer layer of the air bag is used to achieve a good hemostatic effect.

[0004] However, when the patient has severe bleeding and needs to stop bleeding in both nasal cavities at the same time, the left and right air bags of the above-mentioned nasal hemostat are inserted into the nasal cavity at the same time, which will block the nasal cavity and cause the patient to breathe only through the mouth. Long-term mouth breathing will cause prolonged dryness of the throat and oral mucosa, which is uncomfortable to use. Utility Model Content

[0005] The utility model aims to provide a nasal hemostasis device, which solves the problem that when a patient has severe bleeding and needs to stop bleeding in both nasal cavities at the same time, the left air bag and the right air bag of the above-mentioned nasal hemostasis device are inserted into the nasal cavity at the same time, which will block the nasal cavity, causing the patient to have to breathe through the mouth. Long-term mouth breathing will cause the throat and oral mucosa to become dry for a long time, which is uncomfortable to use.

[0006] To achieve the above-mentioned purpose, the utility model provides a nasal hemostasis device, including an inflation component and a hemostasis component;

[0007] The hemostasis component includes a limit block, a hollow tube, a slider and a medicine applying component. There are two sliders, and the two sliders are respectively slidably connected to the limit block. The two sliders are located on the top of the limit block. The tops of the two sliders are respectively fixedly connected with the hollow tubes. The hollow tube has a hollow hole, the slider has a connecting hole, and the limit block has a through groove. The hollow hole, the connecting hole and the through groove are respectively connected to each other. The medicine applying component is connected to the hollow tube, and the inflation component is connected to the medicine applying component.

[0008] Wherein, the medicine applying component comprises an airbag layer and hemostatic cotton, the surface walls of the two hollow tubes are fixedly connected with the airbag layer; the surface walls of the two airbag layers are fixedly connected with the hemostatic cotton.

[0009] Wherein, the hemostasis component further comprises an adhesive layer, and the adhesive layer is fixedly connected to the limiting block and is located on the surface wall of the limiting block.

[0010] Among them, the inflation component includes a three-way hose, an air bag and a valve, the two ends of the three-way hose are respectively connected to the two air bag layers, and the third end of the three-way hose is connected to the air bag; the number of the valves is two, and the two valves are respectively connected to the two ends of the three-way hose.

[0011] Wherein, the inflatable component also includes ear hooks, the number of the ear hooks is two, and the two ear hooks are respectively connected to the two ends of the three-way hose.

[0012] The utility model provides a nasal hemostasis device, wherein the two hollow tubes can slide on the limit block through the slider, and the distance between the two hollow tubes can be adjusted to make them suitable for the patient's nasal cavity, and the limit block is used to integrate the two hollow tubes to facilitate the stabilization of the position of the central tube, and the surfaces of the two hollow tubes are respectively provided with the medicine applying components, and the medicine applying components are used to press and stop bleeding, and the hollow holes, the connecting holes and the through grooves are connected so that the patient can breathe through them. When the patient has severe bleeding and needs to block the two nasal cavities for a long time to stop bleeding, the two central tubes are inserted into the patient's nasal cavity, and the medicine applying components contact the inside of the nasal cavity to press and stop bleeding. At this time, the patient breathes through the hollow holes, the connecting holes and the through groove, and normal breathing is not hindered while stopping bleeding, which makes it more comfortable to use. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below.

[0014] Figure 1 It is a schematic diagram of the overall structure of the nasal hemostasis device of the first embodiment of the utility model.

[0015] Figure 2 It is a cross-sectional view of the nasal hemostasis device of the first embodiment of the utility model.

[0016] Figure 3 It is a schematic diagram of the overall structure of the nasal hemostasis device of the second embodiment of the utility model.

[0017] In the figure: 101-limiting block, 102-hollow tube, 103-slider, 104-hollow hole, 105-connecting hole, 106-through groove, 107-air bag layer, 108-hemostatic cotton, 109-adhesive layer, 201-three-way hose, 202-air bag, 203-valve, 204-ear hook. DETAILED DESCRIPTION

[0018] Embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, but should not be understood as limiting the present invention.

[0019] The first embodiment of the present application is:

[0020] See also Figure 1 and Figure 2 ,in, Figure 1 It is a schematic diagram of the overall structure of the nasal hemostasis device of the first embodiment of the utility model. Figure 2 It is a cross-sectional view of the nasal hemostasis device of the first embodiment of the utility model.

[0021] The utility model provides a nasal hemostasis device: comprising an inflation component and a hemostasis component, the hemostasis component comprising a limit block 101, a hollow tube 102, a slider 103, an adhesive layer 109 and a medicine applying component, the medicine applying component comprising an air bag layer 107 and hemostatic cotton 108, the hollow tube 102 having a hollow hole 104, the slider 103 having a connecting hole 105, and the limit block 101 having a through groove 106. The above-mentioned scheme solves the problem in the background technology that when the patient has severe bleeding and needs to stop bleeding in both nasal cavities at the same time, the left air bag and the right air bag of the above-mentioned nasal hemostat are simultaneously inserted into the nasal cavity, which will block the nasal cavity, causing the patient to only breathe through the mouth. Long-term mouth breathing will cause the throat and oral mucosa to appear dry for a long time, which is uncomfortable to use. It can be understood that the above-mentioned scheme can be used for nasal hemostasis, and can also be used to solve the problem of pressing wounds to stop bleeding.

[0022] According to this specific embodiment, there are two sliders 103, and the two sliders 103 are respectively slidably connected to the limit block 101, and the two sliders 103 are located at the top of the limit block 101. The tops of the two sliders 103 are respectively fixedly connected with the hollow tube 102, and the hollow tube 102 has a hollow hole 104, and the slider 103 has a connecting hole 105. The limit block 101 has a through groove 106, and the hollow hole 104, the connecting hole 105 and the through groove 106 are respectively connected to each other, the medicine applying component is connected to the hollow tube 102, and the inflation component is connected to the medicine applying component. The two hollow tubes 102 can slide on the limiting block 101 through the slider 103 respectively, and the distance between the two hollow tubes 102 is adjusted to make them suitable for the patient's nasal cavity. The two hollow tubes 102 are integrated by the limiting block 101 to facilitate fixing the positions of the two hollow tubes 102. The medicine applying component is arranged on the surface of the two hollow tubes 102 to press and stop bleeding. The patient's breathing enters and exits through the hollow hole 104, the connecting hole 105 and the through groove 106.

[0023] The airbag layer 107 is fixedly connected to the surface wall of the two hollow tubes 102; the hemostatic cotton 108 is fixedly connected to the surface wall of the two airbag layers 107. The airbag layer 107 is fixed to the outer wall of the hollow tube 102, and is connected to the inflation component to inflate and press the nasal cavity to stop bleeding. The hemostatic cotton 108 is arranged on the outer wall of the airbag layer 107 to absorb bleeding in the nasal cavity.

[0024] Secondly, the adhesive layer 109 is fixedly connected to the stop block 101 and is located on the surface wall of the stop block 101. The adhesive layer 109 is fixed to the surface wall of the stop block 101, has stickiness, can be attached to human skin, and then fixes the stop block 101, conveniently fixes the hollow tube 102, does not fall off, and is more stable when inserted into the nasal cavity, and is more comfortable to use.

[0025] When using a nasal hemostasis device of the present embodiment, when both nasal cavities of a patient bleed severely at the same time and both nasal cavities need to be hemostatically controlled for a long time, the two sliders 103 are pushed, the distance between the two hollow tubes 102 is adjusted to make them suitable for the patient's nasal cavity, and then the two hollow tubes 102 are respectively inserted into the two nasal cavities of the patient. At this time, the adhesive layer 109 is attached to the patient's skin to fix the limit block 101, and then the two airbag layers 107 are inflated by the inflation component to make the hemostatic cotton 108 squeeze the surface of the patient's nasal cavity for hemostasis. At this time, the patient breathes through the hollow hole 104, the connecting hole 105 and the through groove 106, which will not hinder the patient's breathing. The device is suitable for long-term hemostasis and is more comfortable to use.

[0026] The second embodiment of the present application is:

[0027] Based on the first embodiment, please refer to Figure 3 ,in, Figure 3 It is a schematic diagram of the overall structure of the nasal hemostasis device of the second embodiment of the utility model.

[0028] The inflation component of this embodiment includes a three-way hose 201 , an air bag 202 , a valve 203 and an ear hook 204 .

[0029] According to this specific embodiment, the two ends of the three-way hose 201 are respectively connected to the two airbag layers 107, and the third end of the three-way hose 201 is connected to the airbag 202; there are two valves 203, and the two valves 203 are respectively connected to the two ends of the three-way hose 201. The front two ends of the three-way hose 201 are respectively connected to the two airbag layers 107, and the third end is connected to the airbag 202. The two airbag layers 107 are inflated by pressing the airbag 202. The two valves 203 are respectively arranged at the front two ends of the three-way hose 201 to control the inflation of the two airbag layers 107. When one of the valves 203 is closed, one nasal cavity can be pressed to stop bleeding.

[0030] There are two ear hooks 204, which are respectively connected to the two ends of the three-way hose 201. The two ear hooks 204 are sleeved on the front two ends of the three-way hose 201, and can be adjusted in position by sliding, and can be hung on the patient's ears, so as to fix the limit block 101 and prevent the medicine applying component from falling off during the hemostasis process.

[0031] When using a nasal hemostasis device of the present embodiment, after the two hollow tubes 102 are inserted into the patient's nasal cavity, the position of the ear hook 204 is adjusted and hung on the patient's ear, the valve 203 is opened, the air bag 202 is pressed, and the two air bag layers 107 are inflated to press the patient's nasal cavity to stop bleeding. The ear hook 204 and the patient's ear are used for support to prevent the hollow tube 102 from falling off, thereby achieving a better use effect.

[0032] What is disclosed above is only one or more preferred embodiments of the present application, and cannot be used to limit the scope of rights of the present application. Ordinary technicians in this field can understand that all or part of the processes of implementing the above embodiments and equivalent changes made according to the claims of the present application are still within the scope covered by the present application.

Claims

1. A nasal hemostasis device, comprising an inflation component, characterized in that: Also included is a hemostasis component; The hemostasis component includes a limit block, a hollow tube, a slider and a medicine applying component. There are two sliders, and the two sliders are respectively slidably connected to the limit block. The two sliders are located on the top of the limit block. The tops of the two sliders are respectively fixedly connected with the hollow tubes. The hollow tube has a hollow hole, the slider has a connecting hole, and the limit block has a through groove. The hollow hole, the connecting hole and the through groove are respectively connected to each other. The medicine applying component is connected to the hollow tube, and the inflation component is connected to the medicine applying component.

2. The nasal hemostasis device according to claim 1, characterized in that: The medicine applying component comprises an air bag layer and hemostatic cotton. The surface walls of the two hollow tubes are fixedly connected with the air bag layer; the surface walls of the two air bag layers are fixedly connected with the hemostatic cotton.

3. The nasal hemostasis device according to claim 1, characterized in that: The hemostasis component also includes an adhesive layer, which is fixedly connected to the limiting block and is located on the surface wall of the limiting block.

4. The nasal hemostasis device according to claim 2, characterized in that: The inflation component includes a three-way hose, an air bag and a valve. The two ends of the three-way hose are respectively connected to the two air bag layers, and the third end of the three-way hose is connected to the air bag. There are two valves, and the two valves are respectively connected to the two ends of the three-way hose.

5. The nasal hemostasis device according to claim 4, characterized in that: The inflatable component also includes two ear hooks, and the two ear hooks are respectively connected to the two ends of the three-way hose.

Citation Information

Patent Citations

  • Haemostatic device for nasal cavity

    CN202060822U